The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Lilly; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Novartis; PharmaMar
Travel, Accommodations, Expenses - Lilly; Novartis; PharmaMar
Treatment of angiosarcoma with pazopanib and paclitaxel: Results of the phase II trial of the German Interdisciplinary Sarcoma Group (GISG-06 EVA) study.
 
Daniel Pink
Honoraria - Lilly; Novartis; PharmaMar
Research Funding - Lilly; PharmaMar
Travel, Accommodations, Expenses - Lilly; Novartis; PharmaMar
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Lilly; Nanobiotix
Research Funding - Blueprint Medicines; Incyte (Inst); Novartis
Travel, Accommodations, Expenses - Pharmamar
 
Thomas Brodowicz
Honoraria - Amgen; Bayer; Eisai; Lilly; Novartis; PharmaMar; Roche
Consulting or Advisory Role - Amgen; Bayer; Eisai; Lilly; Novartis; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Peter Reichardt
Honoraria - Bayer; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - ARIAD; Clinigen Group; Lilly; Merck; Novartis; Pfizer; PharmaMar; Roche
Research Funding - Novartis (Inst)
 
Bernd Kasper
No Relationships to Disclose
 
Stephan Richter
No Relationships to Disclose
 
Peter Hohenberger
Honoraria - Eisai; Lilly; Novartis; Pfizer
Consulting or Advisory Role - Arog; Eisai; Lilly; Nanobiotix; Novartis; PharmaMar
Travel, Accommodations, Expenses - PharmaMar